Top Markets
#1 Nesa Nesa +804.64%
#2 Cortex Cortex +68.20%
#3 Kinesis Silver Kinesis Silver +55.47%
#4 QuantixAI QuantixAI +23.95%
#5 EXOD EXOD +22.78%
#6 Alchemist AI Alchemist AI +20.66%
#7 Cash Cat Cash Cat +20.55%
#8 Pons Pons +18.96%
#9 OpenEden OpenEden +15.77%
#10 Pyth Network Pyth Network +14.03%
Coin of the day
Nesa Nesa
Settings
Language
ENGLISH
Currency
USD
Theme
Cypherpunk Technologies Inc. Cypherpunk Technologies Inc.

Cypherpunk Technologies Inc.

CYPH
Rank in Stocks #19170
Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the... Cypherpunk Technologies Inc. is a biopharmaceutical company dedicated to the acquisition and development of antibody treatments for cancer. The firm's flagship investigational drug, DKN-01, is a monoclonal antibody designed to suppress Dickkopf-related protein 1 and is currently progressing through multiple clinical trials for various esophagogastric, gynecologic, and colorectal cancers. Additionally, the company is advancing FL-501, another monoclonal antibody that targets the GDF-15 protein, which is presently in preclinical development. Cypherpunk has established an agreement with Adimab, LLC and BeiGene, Ltd., granting it options and licenses to advance and market DKN-01 across Asia (excluding Japan), Australia, and New Zealand. Founded in 2011, the company operates from Cambridge, Massachusetts, and was formerly known as Leap Therapeutics, Inc. until its renaming in November 2025.
Share Price
$1.62
Last synced: 2026-08-25
Market Cap
$172.47M
Change (1 day)
-3.57%
Change (1 year)
446.74%
Country
US
Trade Cypherpunk Technologies Inc. (CYPH)

Category

Healthcare
Stock price history for Cypherpunk Technologies Inc. (CYPH)
Highest end of day price: $0.94 on 2026-08-01

Lowest end of day price: $75.65 on 2017-01-01
Stock price history of Cypherpunk Technologies Inc. from 2017 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -31.92%
2025 -58.69%
2024 -5.41%
2023 -33.87%
2022 -82.32%
2021 38.52%
2020 121.83%
2019 -68.29%
2018 -56.56%
2017 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 44.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 541.49%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.62 -12.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $769.41 6.94%
CH